Fundraising Fox
🦊/People
Sign in

Briggs Morrison

Investor

Entrepreneur Partner at MPM BioImpact · Board director at Crossbow Therapeutics · Board director at Werewolf Therapeutics · Board director at Oncorus

Newtown, Pennsylvania, United States

Find your path to Briggs

457 people in our graph share verified history with Briggs — schools, employers, funds. One of them is your warm intro.

Catherine Pearce, DHSc, MBAunlockedBriggs: together at Merck & Co., Inc (1999–2002)
×2Briggs: together at Merck & Co., Inc
Briggs: together at Georgetown
Briggs: together at Pfizer

About

Entrepreneur Partner and CEO of portfolio company Crossbow Therapeutics. Served as Chief Medical Officer and Executive Vice President for Global Medicines Development at AstraZeneca with experience overseeing clinical development at Pfizer and Merck.

Board director at Crossbow Therapeutics

Intro paths

→

In turn, Briggs can intro founders to Crossbow Therapeutics's investors below.

Crossbow Therapeutics's investors · 7

Biotechnology Value FundSan Francisco · since 2023Mirae Asset Venture Investment$594K – $54M checks · since 2023MPM BioImpactBoston · $1M – $15M checks · since 2025Pfizer Venture Investments$5M – $20M checksPfizer Venturessince 2026Polaris PartnersBoston · $500K – $5M checks · since 2025Taiho Ventures, LLCMenlo Park · since 2026

Board director at Werewolf Therapeutics

Intro paths

→

In turn, Briggs can intro founders to Werewolf Therapeutics's investors below.

Werewolf Therapeutics's investors · 6

DC Investment PartnersMcLean · $10M checks · since 2020K2 HealthVenturesBoston · $10M – $100M checks · since 2020Longwood FundBoston · since 2020MPM BioImpactBoston · $1M – $15M checks · since 2020RA CapitalBoston · since 2020Taiho Ventures, LLCMenlo Park · since 2020

Co-founders at Werewolf Therapeutics

DJ
Daniel J. HicklinFounder, President, Chief Executive Officer, and Board member
LELuke Evnin
Luke EvninCo-founder, Board member (Chairman)
DH
Daniel HicklinExecutive Officer, Director

Board director at Oncorus

Intro paths

→

In turn, Briggs can intro founders to Oncorus's investors below.

Oncorus's investors · 4

Astellas Venture Management LLCSouth San Francisco · $200K – $5M checksCowen Healthcare InvestmentsNew YorkDeerfield Management CompanyNew YorkMPM BioImpactBoston · $1M – $15M checks · since 2016

Experience

  1. ArvinasBoard Chaircurrent2026 — presentNew Haven, Connecticut, United States
  2. ArvinasBoard Member2018 — 2026New Haven, Connecticut, United States
  3. CRISPR TherapeuticsBoard Membercurrent2025 — presentBoston MA and Zug Switzerland
  4. Crossbow Therapeutics, IncChief Executive Officercurrent2022 — presentCambridge, Massachusetts, United States
  5. Werewolf TherapeuticsBoard Membercurrent2019 — presentBoston, Massachusetts, United States
  6. MPM BioImpactExecutive Partnercurrent2015 — presentCambridge, MA
  7. Syndax PharmaceuticalsBoard Member2015 — 2024
  8. Syndax PharmaceuticalsPresident, Head of R+D2022 — 2023
  9. Syndax PharmaceuticalsCEO2015 — 2022Waltham, MA/ New York City
  10. AstraZenecaChief Medical Officer and Executive Vice President, Global Medicines Development2012 — 2015Wilmington, Delaware
  11. PfizerSVP2007 — 2011New York City Metropolitan Area
  12. Merck & Co., Incvarious1995 — 2007Rahway, NJ

Deals · 1

OncorusBoard seat

via MPM BioImpact · filed Sep 2018 · $61.4M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: SEC Form D filings · curated public sources.

Colleagues at MPM BioImpact

Alan Kelly
Director at MPM BioImpact
Andrew Scharenberg
Entrepreneur Partner at MPM BioImpact
Ansbert Gadicke, M.D.
Chairman at MPM BioImpact
Ansbert K. Gadicke
Managing Partner at MPM BioImpact
Aparna Parikh
Entrepreneur Partner at MPM BioImpact
Bard Geesaman
Managing Partner at MPM Capital
Binsen Li
Principal at MPM BioImpact
Brendan Furey
Chief Compliance Officer at MPM BioImpact

Network10

Ansbert K. Gadicke
Managing Partner at MPM BioImpact
Bard Geesaman
Managing Partner at MPM Capital
Dan Hicklin
Managing Partner at MPM Capital
David Kolesky
Principal at MPM BioImpact
David Stack
Managing Partner at MPM Capital
Detlev Biniszkiewicz
Managing Director at MPM BioImpact
Devin Quinlan
Principal at MPM BioImpact
Ed Hurwitz
Managing Director at MPM Capital
Elizabeth Stoner
Entrepreneur Partner at MPM BioImpact
Gary Patou
Managing Director at MPM Capital

Investors connected to Briggs in public investor directories — a warm-intro map.

Frequently asked questions

Who is Briggs Morrison?
Entrepreneur Partner and CEO of portfolio company Crossbow Therapeutics. Served as Chief Medical Officer and Executive Vice President for Global Medicines Development at AstraZeneca with experience overseeing clinical development at Pfizer and Merck.
Where does Briggs Morrison work?
Briggs Morrison is Entrepreneur Partner at MPM BioImpact and Board director at Crossbow Therapeutics and Board director at Werewolf Therapeutics and Board director at Oncorus.
What boards does Briggs Morrison sit on?
Briggs Morrison holds tracked board seats at Oncorus, Werewolf Therapeutics.
What companies has Briggs Morrison invested in?
Investments tracked here include Photys Therapeutics, Inc..
Where did Briggs Morrison go to school?
Briggs Morrison studied at Dana Farber Cancer Institute (Fellowship, Medical Oncology); Mass General Hosipital (Intern/Resident, Internal Medicine); The University of Connecticut Health Center (MD, Medicine).

Founder mafias

The University of Connecticut Health Center mafia4

Also came through, then founded or led a company.

Tim ShannonFounded Quarry TheraRobin Hyde-DeRuyscherPhDFounded Emergo TherapeuticsDavid W. SalzmanPh.D.Founded Gatehouse Bio

Crossbow Therapeutics mafia2

Also came through, then founded or led a company.

Todd FoleyDirectorFounded Aktis Oncology

Same school

Shared employers